europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

02/02/2021
REPORT

Measuring the economic footprint of the Biotechnology Industry in Europe

The purpose of this study is to estimate the economic impact of the production activities of European enterprises applying biotechnology in their research and manufacturing processes. The analysis covers the years between 2008 and 2018 while focusing on contributions to economic growth and employment. Especially estimations of direct as well as indirect and induced effects (so-called spillover effects) are considered, in total tagged as “footprint”. The impact is analysed regarding to employment and contribution to gross domes-tic product (GDP), the latter being measured in terms of gross value added (GVA). Therefore, this economic footprint analysis provides an overall eco-nomic picture of the EU biotechnology industry supplemented by trade and R&D figures. It sheds light on the performance of the industry, its direct contribution to Europe’s GDP and labour market, as well as on the spillover effects occurring in European supply chains.

The study computes the impact of the biotechnology industry operating in 28 EU member countries. A detailed description of data sources and methodology can be found in Appendix B.

The results show that the biotechnology industry has contributed €34.5 bn GVA to the growth of the European economy in 2018. If indirect and induced effects are considered, this amount increases to €78.7 bn. This simply means that every Euro of GVA directly generated by the biotechnology industry sup-ports additionally €1.3 GVA in the European economy.

Furthermore, the biotechnology industry accomplished to safeguard up to 223,000 jobs directly and supports 710,500 jobs along the value chain, mainly created by the suppliers of goods and services to the biotechnology industry. Or to put it differently, for each job in the biotechnology industry there are 3.2 additional jobs in the overall economy. Detailed figures on the three biotechnology sub-sectors can be found in Chapter 2.

This study was commissioned by EuropaBio, the European Association of Bioindustries, with the objective to better quantify the impact of the biotechnology industry on the European Union’s economy.

Founded in 1996, EuropaBio is the recognised voice of the EU biotechnology community, championing world-class solutions for society’s challenges. EuropaBio and its members are committed to the responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a bio-based and zero-waste economy.



Download below the SUMMARY (3 pages) or the FULL REPORT (52 Pages).

EuropaBio - WifOR Study - FULL REPORT


Download

EuropaBio - WifOR Study - SUMMARY


Download

201208_WifOR_EuropaBIO_Economic_Impact_Biotech_FINALDownload
2021_02_G_REPORT_EuropaBio-WifOR_Economic_Footprint_Biotechnology_SummaryDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more
19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member